1. Home
  2. GHRS vs VTEX Comparison

GHRS vs VTEX Comparison

Compare GHRS & VTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • VTEX
  • Stock Information
  • Founded
  • GHRS 2018
  • VTEX 1999
  • Country
  • GHRS Ireland
  • VTEX Cayman Islands
  • Employees
  • GHRS N/A
  • VTEX N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • VTEX Computer Software: Prepackaged Software
  • Sector
  • GHRS Health Care
  • VTEX Technology
  • Exchange
  • GHRS Nasdaq
  • VTEX Nasdaq
  • Market Cap
  • GHRS 774.1M
  • VTEX 757.0M
  • IPO Year
  • GHRS 2021
  • VTEX 2021
  • Fundamental
  • Price
  • GHRS $13.11
  • VTEX $4.24
  • Analyst Decision
  • GHRS Strong Buy
  • VTEX Strong Buy
  • Analyst Count
  • GHRS 9
  • VTEX 4
  • Target Price
  • GHRS $29.33
  • VTEX $7.63
  • AVG Volume (30 Days)
  • GHRS 319.1K
  • VTEX 1.0M
  • Earning Date
  • GHRS 11-13-2025
  • VTEX 11-04-2025
  • Dividend Yield
  • GHRS N/A
  • VTEX N/A
  • EPS Growth
  • GHRS N/A
  • VTEX 48.79
  • EPS
  • GHRS N/A
  • VTEX 0.05
  • Revenue
  • GHRS N/A
  • VTEX $230,497,000.00
  • Revenue This Year
  • GHRS N/A
  • VTEX $10.08
  • Revenue Next Year
  • GHRS N/A
  • VTEX $14.18
  • P/E Ratio
  • GHRS N/A
  • VTEX $80.94
  • Revenue Growth
  • GHRS N/A
  • VTEX 4.53
  • 52 Week Low
  • GHRS $6.72
  • VTEX $3.92
  • 52 Week High
  • GHRS $20.50
  • VTEX $7.14
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 47.63
  • VTEX 41.86
  • Support Level
  • GHRS $12.26
  • VTEX $4.27
  • Resistance Level
  • GHRS $13.65
  • VTEX $4.62
  • Average True Range (ATR)
  • GHRS 0.75
  • VTEX 0.15
  • MACD
  • GHRS -0.08
  • VTEX 0.01
  • Stochastic Oscillator
  • GHRS 31.37
  • VTEX 12.50

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

Share on Social Networks: